Background

Personality is a unique pattern of behavior through which individuals perceive and react to the world, and has long been a major area of exploration in psychology and behavioral science. In clinical settings, observations have steadily accumulated showing that personality traits such as neuroticism or extraversion are closely linked to the risk of developing depression, cardiovascular disease, and metabolic syndrome. However, observational studies alone made it difficult to clearly determine whether specific personality traits cause diseases, or whether underlying diseases or common environmental factors influenced personality formation. This hit a limit in clearly proving the sequence of causality.

Existing genomic studies also failed to fully clarify the polygenic nature of personality due to constraints in sample size. Because human behavior and traits are shaped by the complex interplay of numerous minor genetic variants, it was difficult to achieve statistical significance with cohorts in the tens of thousands. This lack of samples has also been a long-standing obstacle in research revealing the shared biological mechanisms between mental and physical diseases. Furthermore, there was also a lack of large-scale analysis infrastructure to correct for the subjective bias inherent in self-reported survey data. Researchers have now embarked on a study to elucidate the genetic structure of personality traits and rigorously verify their potential causality with diseases by integrating large-scale genomic data from over one million people.

Key Findings

Researchers performed a Genome-Wide Association Study (GWAS) on a multinational cohort of over one million people to identify numerous genetic variants involved in personality traits. This achievement precisely identified genomic loci associated with major personality scales such as extraversion, neuroticism, and conscientiousness and verified their statistical associations. The study is evaluated to have dramatically increased statistical power compared to previous studies by combining vast genotypic data with personality phenotypes. Subsequently, they applied Mendelian Randomization (MR), using genetic variants as instrumental variables, to trace the causal pathways between personality traits and health outcomes.

Analysis results indicated that genetic variants associated with neuroticism traits had potential causal effects not only on major depressive disorder and anxiety disorders but also on coronary artery disease and elevated chronic inflammation markers. This result supports the idea that high emotional instability can cause disturbances in the neuroendocrine and immune systems in the long term, increasing the risk of physical diseases. Conversely, genetic indicators associated with conscientiousness and extraversion were directly linked to protective effects, such as regular physical activity, reduced smoking rates, and longer lifespan. This point statistically demonstrates that, beyond simple correlations between personality and physical diseases, common genetic variants and biological pathways can directly contribute to disease pathogenesis.

Significance and Outlook

This study holds academic value in converting personality traits, which were treated as psychological concepts, into molecular genetic and statistical genetic data. This demonstrates that mental health and physical illnesses interact along a single biological axis, based on large-scale genomic big data. In the future, integrating personality genetic variants into Polygenic Risk Score (PRS) models will lay a solid foundation to significantly increase the predictive precision of personalized preventive medicine.

However, challenges remain to be solved before application in clinical settings. A clear limitation is that the study cohort is predominantly of European ancestry, making it difficult to generalize the results to multi-ethnic populations. Critics also point out that population stratification in complex trait studies, as well as subtle residual confounding factors, cannot be completely excluded. Follow-up research is expected to significantly expand data from non-European populations and link it with brain imaging data and single-cell transcriptome analysis to elucidate the actual mechanisms by which genetic variants affect neural circuit development.